Current Assets
Total Current Assets
Kailera Therapeutics Total Current Assets decreased by 4.9% to $530.32M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
Detailed definition
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Peer comparison
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
Metric ID:
total_current_assetsHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $557.54M | $530.32M |
| QoQ Change | — | -4.9% |
Range$530.32M – $557.54M
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's total current assets?
- Kailera Therapeutics (KLRA) reported total current assets of $530.32M in Q1 2026.
- What does total current assets mean?
- The total value of all assets that can be turned into cash within one year.